Eli Lilly and Company (NYSE: LLY) in its $3.2 billion acquisition of Morphic (NASDAQ: MORF), a biotechnology company
Buyer in acquisition of a controlling interest in $1.2 billion portfolio of net-leased hospitals located in Utah and $770 million financing
Rite Aid Corporation (“Rite Aid”) and 119 of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey
Vista Equity Partners in its $1.25 billion acquisition of Model N (NYSE: MODN)
Ingersoll Rand (NYSE: IR) in its $2.325 billion acquisition of ILC Dover, a provider of solutions for biopharmaceutical, pharmaceutical and medical device markets, from New Mountain Capital
